Symantec Firewall/VPN Appliance MAC Address privileges management
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.3 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Symantec Firewall and VPN Appliance. It has been rated as critical. Affected is an unknown function of the component MAC Address Handler. This manipulation causes privileges management. The identification of this vulnerability is CVE-2002-1937. There is no exploit available.
Details
A vulnerability has been found in Symantec Firewall and VPN Appliance (Firewall Software) (version unknown) and classified as critical. Affected by this vulnerability is an unknown function of the component MAC Address Handler. The manipulation with an unknown input leads to a privileges management vulnerability. The CWE definition for the vulnerability is CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. As an impact it is known to affect integrity. The summary by CVE is:
Symantec Firewall/VPN Appliance 100 through 200R hardcodes the administrator s MAC address inside the firewall s configuration, which allows remote attackers to spoof the administrator s MAC address and perform an ARP poisoning man-in-the-middle attack to obtain the administrator s password.
The weakness was shared 12/31/2002 (Website). It is possible to read the advisory at archives.neohapsis.com. This vulnerability is known as CVE-2002-1937 since 06/29/2005. The exploitation appears to be easy. The attack can be launched remotely. The exploitation doesn't need any form of authentication. The technical details are unknown and an exploit is not publicly available. The pricing for an exploit might be around USD $0-$5k at the moment (estimation calculated on 04/19/2019). The attack technique deployed by this issue is T1068 according to MITRE ATT&CK.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at X-Force (10442). Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Type
Vendor
Name
License
Website
- Vendor: https://www.symantec.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.3VulDB Meta Temp Score: 5.3
VulDB Base Score: 5.3
VulDB Temp Score: 5.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
12/31/2002 🔍12/31/2002 🔍
06/29/2005 🔍
08/05/2014 🔍
04/19/2019 🔍
Sources
Vendor: symantec.comAdvisory: archives.neohapsis.com
Status: Not defined
CVE: CVE-2002-1937 (🔍)
GCVE (CVE): GCVE-0-2002-1937
GCVE (VulDB): GCVE-100-19579
X-Force: 10442 - Symantec Firewall/VPN Appliance ARP request man-in-the-middle attack
Entry
Created: 08/05/2014 11:01Updated: 04/19/2019 20:42
Changes: 08/05/2014 11:01 (47), 04/19/2019 20:42 (2)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.